MDLinx reports that a unique Phase I trial will commence at 4 centers nationwide. Unlike most Phase I cancer studies, this specific study is not organ specific. Meaning, that patients with any solid tumor may participate (e.g cervical cancer, gastric cancer, melanoma, etc.). One of the centers is University of Mississippi Medical Center (UMMC) Cancer Institute. Follow the link to read more about this study.